• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, August 22, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

New study finds cardiovascular rehabilitation helps reduce risk of death in depressed heart patients

Bioengineer by Bioengineer
November 13, 2016
in Science News
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: Intermountain Medical Center Heart Institute

Depression has been known to be associated with poor cardiovascular outcomes, but if patients who are depressed attend cardiac rehabilitation after heart surgery, their risk of death is significantly reduced, according to a new study.

The study, conducted by researchers at Intermountain Medical Center Heart Institute in Salt Lake City, found that patients who were moderately to severely depressed had a higher risk of death after cardiovascular surgery than patients with mild to no depression. However, if those moderately to severely depressed patients attended rehabilitation after surgery, their risk of death was moderately reduced.

"We know the presence of moderate to severe depressive symptoms prior to cardiovascular surgery is a major risk factor for death, but our study shows that if those patients attend cardiac rehabilitation, their risk for death decreases significantly," said the Intermountain Medical Center Heart Institute's Viet Le, MPAS, PA, lead author of the study.

Results of the study will be presented at the 2016 American Heart Association's Scientific Session in New Orleans on Sunday, November 13, at 5 pm, CST.

Several benefits of cardiac rehabilitation may play a role in reducing the risk for death in heart patients after cardiovascular surgery, Le said.

"We think cardiac rehab helps patients to manage their expectations as they return to work and life," he said. "This comes from having a support group of fellow patients who may be further along in their rehab, as well as having exercise and activity protocols managed by experienced staff who can encourage consistent follow-up as well as 'slow' an overly enthusiastic patient. Getting patients out of their home after surgery, where they may overthink the effects of the disease, to a place where their job is to heal can enhance not only their physical recovery but their emotional health."

The research indicates that patients who attend rehabilitation after surgery reduced their risk of death by nearly half, Le said, but further study is required to determine whether other factors contribute to this result, as well.

The Intermountain Medical Center Heart research team compiled information from 118 patients undergoing heart surgery who completed a nine-question patient health questionnaire (PHQ)-9 during an outpatient visit before their surgery.

Patients were categorized based on their results of their survey as having no to mild depressive symptoms or moderate to severe depressive symptoms. Following each patient's completion of the last questionnaire, patients were followed post-surgery to determine the association of pre-surgery PHQ-9 depressive symptoms and death.

At the conclusion of the study, death occurred in 6.1 percent in patients with no to mild depressive symptoms and in about 25 percent of heart patients with moderate to severe depressive symptoms, showing that depressive symptoms were significantly associated with death.

Among patients with moderate to severe depression however, attending cardiac rehabilitation significantly decreased their risk of death by 74 percent (HR=0.26, p=0.02).

###

Other researchers involved in the study include: Tami L. Bair, Jose Benuzillo; Heidi T. May, PhD; Kirk U. Knowlton, MD; Donald L. Lappé, MD; and Joseph B. Muhlestein, MD.

Intermountain Medical Center is the flagship facility for the Intermountain Healthcare system, which is based in Salt Lake City.

Media Contact

Jess C. Gomez
[email protected]
801-718-8495
@IntermtnMedCtr

http://www.ihc.com

Share12Tweet8Share2ShareShareShare2

Related Posts

blank

Biomimetic Magnetobots Revolutionize Pneumonia Treatment

August 22, 2025
ERBB3 Drives Ferroptosis by Altering Lipids in Cancer

ERBB3 Drives Ferroptosis by Altering Lipids in Cancer

August 22, 2025

University of Ottawa Enters the Betavoltaic Battery Commercialization Arena

August 22, 2025

Calcium Testing in Poultry Unlocks Path to Enhanced Feed Efficiency

August 22, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Molecules in Focus: Capturing the Timeless Dance of Particles

    141 shares
    Share 56 Tweet 35
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    114 shares
    Share 46 Tweet 29
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    81 shares
    Share 32 Tweet 20
  • Modified DASH Diet Reduces Blood Sugar Levels in Adults with Type 2 Diabetes, Clinical Trial Finds

    60 shares
    Share 24 Tweet 15

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Biomimetic Magnetobots Revolutionize Pneumonia Treatment

ERBB3 Drives Ferroptosis by Altering Lipids in Cancer

University of Ottawa Enters the Betavoltaic Battery Commercialization Arena

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.